Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNMC.L Regulatory News (NMC)

  • There is currently no data for NMC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - NMC Health plc

14 Feb 2020 13:49

RNS Number : 0998D
Franklin Resources, Inc
14 February 2020
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Franklin Resources, Inc.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

NMC Health plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

13 February 2020

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

10p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

236,800

0.11%

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

236,800

0.11%

 

 

 

 

 

 

 

Class of relevant security:

 

Convertible bond 2025

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

21,400,000

5.94%

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

21,400,000

5.94%

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

10p ordinary

Transfer in of discretionary holdings

627 shares

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

 

 

 

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

14 February 2020

Contact name:

Cathy Johnson

Telephone number*:

954-527-7580

subsshholder@franklintempleton.com

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETXZLFFBLLZBBQ
Date   Source Headline
27th Apr 202012:40 pmRNSHolding(s) in Company
27th Apr 20207:55 amRNSCancellation of Listing
22nd Apr 20206:10 pmRNSNMC Health
22nd Apr 202010:20 amRNSHolding(s) in Company
22nd Apr 202010:15 amRNSHolding(s) in Company
21st Apr 20207:00 amRNSHolding(s) in Company
21st Apr 20207:00 amRNSHolding(s) in Company
21st Apr 20207:00 amRNSHolding(s) in Company
17th Apr 202012:40 pmRNSHolding(s) in Company
16th Apr 20206:00 pmRNSNMC Health
16th Apr 202010:05 amRNSAdditional Board Disclosures
14th Apr 20207:00 amRNSBoard Changes
9th Apr 20206:35 pmRNSNMC Health
9th Apr 20202:30 pmRNSAlvarez & Marsal appointed as administrators
8th Apr 20204:30 pmRNSHoldings in Company
8th Apr 20203:09 pmRNSStatement re. administration application by ADCB
6th Apr 20204:30 pmRNSHoldings in Company
6th Apr 20207:00 amRNSStatement regarding Abu Dhabi Commercial Bank
3rd Apr 20209:30 amRNSHoldings in Company
26th Mar 20204:09 pmRNSBoard Changes
25th Mar 20206:20 pmRNSNMC Health
25th Mar 202012:30 pmRNSHoldings in Company
25th Mar 202012:30 pmRNSHoldings in Company
25th Mar 202012:30 pmRNSHoldings in Company
24th Mar 20209:46 amRNSUpdate on financial position
23rd Mar 202010:00 amRNSHoldings in Company
17th Mar 20206:30 pmRNSNMC Health
13th Mar 20206:27 pmRNSNMC Health
12th Mar 20208:31 amRNSUpdate regarding independent review
10th Mar 20204:11 pmRNSUpdate on financial position
10th Mar 20203:20 pmRNSForm 8.3 - NMC Health plc
10th Mar 202010:55 amRNSForm 8.5 (EPT/RI) - NMC Health plc
9th Mar 20205:51 pmRNSForm 8.5 (EPT/RI) - Amendment
9th Mar 20204:18 pmRNSStatement regarding NMC Health plc
9th Mar 20202:21 pmRNSForm 8.3 - NMC Health PLC
9th Mar 202012:21 pmRNSForm 8.3 - NMC Health plc
9th Mar 202012:16 pmRNSForm 8.3 - NMC Health plc
9th Mar 202012:15 pmRNSForm 8.3 - NMC Health plc
9th Mar 202012:07 pmRNSForm 8.3 - NMC Health plc
9th Mar 202012:05 pmRNSForm 8.3 - NMC Health plc
9th Mar 202012:02 pmRNSForm 8.3 - NMC Health plc
9th Mar 202011:52 amRNSForm 8.3 - NMC Health plc
9th Mar 202011:49 amRNSForm 8.3 - NMC Health plc
9th Mar 202011:45 amRNSForm 8.3 - NMC Health plc
9th Mar 202011:44 amRNSForm 8.3 - NMC Health plc
9th Mar 202011:37 amRNSForm 8.3 - NMC Health plc
6th Mar 20203:20 pmRNSForm 8.3 - NMC Health plc
6th Mar 20203:20 pmGNWDavidson Kempner Capital Management LP : Form 8.3 - NMC Health plc
6th Mar 20202:26 pmRNSStatement regarding major shareholdings
6th Mar 202011:43 amRNSForm 8.3 - NMC Health plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.